Antibiotic microsphere beads are small, time release antibiotic beads that proceed to release antibiotics over a period of time once implanted or inserted inside the body to fight infection when it is most needed. Terry Clyburn, M.D, at Houston Methodist ?rth?pedics and Sports Medicine developed these tiny antibiotic beads, which are as small as grains of salt, to aid in combating infections. He has been working for over 15 years to perfect these microspheres.
There is a risk of infection involved post any surgery. However, if there are post-surgery infections after joint replacement surgeries, these are harder to treat as the implants are not linked to the body’s blood flow. Hence, the medication sent to fight the infection cannot reach and target the bacteria in the implant. Therefore, usually the patients undergoing joint replacement are placed on intravenous antibiotics prior to and after the surgery to reduce the incidence of infection. Antibiotic microsphere beads can be coated on to the implant itself prior to placing it in the patients joint owing to which the antibiotics are delivered straight to the surgical site, which aids in preventing an infection from developing. Once implanted at the site, the antibiotic microsphere beads are devised to release antibiotics at a level that is high enough to treat infections for at least the next three to six weeks. This is a time frame when infections are most likely to erupt.
There is another medication that is classified as time release medication, which in most cases releases the drug once the outer protective covering is dissolved inside the body. However, these antibiotic microspheres are truly extended time release, as these have multiple layers that dissolve over time and deliver medication over the implant and its surrounding tissues. Over a span of six weeks, the microspheres dissolve completely ensuring that the patient fights off infections, leaving no residue behind that could be harmful to the patient. In order to test efficacy of these antibiotic microspheres, experiments were conducted where metal implants were knowingly infected with bacteria, and then coated in microspheres and inserted inside animal models. There was no sign of infection in the implant coated with the antibiotic microspheres. According to a study, around 10,000 in over 1 million people who undergo total joint replacements annually will develop infections. Antibiotic microsphere beads can play a vital role in reducing the number of infections, by slowly releasing the antibiotic over several weeks to starve off infections. Infections that are caused post-surgery can manifest immediately post-surgery or sometimes weeks or years after the surgery. When the infection spreads and surpasses the superficial tissues and gains access deep into the replacement joint, it mostly requires a surgical intervention. The use of antibiotic microspheres will eliminate that.
Mr. Clyburn has produced the microspheres in collaboration with Catherine Ambrose, Ph.D., from UTHealth and Rice University's Antonios Mikos, Ph.D. Mr. Clyburn is seeking FDA approval of the antibiotic microspheres and estimates that the microspheres will be in use in around next three to eight years. Once these receive FDA approval, antibiotic microsphere beads are expected to considerably eliminate the chances of post joint replacement surgery infections, thereby saving the patient from possible complications and trauma.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.